Table 7: Composite Symptomatic Relief & Antacid Use in Undifferentiated NERD over 28 Days.
|
Composite Responders |
Composite Non-Responders |
Percent Antacid Use |
PPSBT |
87.3 (n = 48 of 55) |
12.7 (n = 7 of 55) |
12.5 (n = 20 of 160 btls) |
Placebo |
18.4 (n = 9 of 49) |
81.6 (n = 40 of 49) |
75.7 (n = 109 of 144 btls) |